Detailed findings from our Phase 3 MANIFEST-2 trial in first-line #myelofibrosis will be showcased in an oral presentation tomorrow at #ASH23. Information about the presentation can be found here: bit.ly/3uRq4FE

We presented comprehensive results at #ASH23 from our Phase 3 MANIFEST-2 study in first-line #myelofibrosis. Read our press release for more information: bit.ly/3uLPWTi

Yesterday, members of our team attended the MA Conf. for Women Conference. We heard inspiring words from Jacinda Ardern, Margaret E Atwood, America Ferrera and more, and learned about leading with empathy, combatting imposter syndrome and the importance of women in leadership. #MassWomen

Our CEO, Jean-Paul Kress, M.D., is presenting at #JPM24 on Wednesday, January 10, at 3:00 p.m. PST in San Francisco. Join via webcast for an overview of our key #oncology clinical programs and upcoming catalysts.​ More here: bit.ly/3TNz49n

Herbert van Ass, VP, Head of Human Resources AG, believes effective teamwork is essential for success. Since joining our team, he’s seen an immense amount of positivity and motivation from colleagues who strive to go the extra mile. #MissionToDoMore

This year, #BlackHistoryMonth is focused on celebrating the enduring influence of Black artists, filmmakers, writers, musicians and more. We’re recognizing them by educating our team on their creative legacy and the incredible contributions they’ve made to American culture.

Last year, we formed a Myelofibrosis Patient and Caregiver Insights Council to gather community perspectives to inform our direction and decisions. Hearing the needs of people like Amy helps us take steps to #ClosetheCareGap. Learn more: bit.ly/47Vjr2Y #WorldCancerDay

We entered into agreements to be acquired by Novartis & to sell all rights of our CD19-directed immunotherapy to Incyte. Tune into our webcast on 2/6, at 2PM CET/8AM EST & read our press release for more information, including details for shareholders: bit.ly/491h7ZK

On International Day of #WomenandGirlsinScience, we celebrate the achievements of women in these fields, especially the accomplished women on our team. Helping ensure equal opportunity for women and girls in science is essential to empower the next generation to pursue this work.

For Michael, caring for his wife Jan living with cancer can feel like a full-time job, but he knows #caregivers need care, too. On #NationalCaregiversDay, we honor people like Michael who provide selfless support. See The Leukemia & Lymphoma Society for caregiver resources: bit.ly/49xoOq8

On #IWD2024, we celebrate the amazing women on our team and applaud those working to forge more inclusive workplaces. We strive to #InspireInclusion by championing women in leadership, encouraging allyship and empowering women to succeed.

We reported our Q4 and full year 2023 financial results. Join our live webcast tomorrow, March 14, at 1:00 p.m. CET / 8:00 a.m. EDT and read our press release for more information, including important details for stockholders: bit.ly/3IBswUh

2023 was a critical and exciting year for our company. Our progress is a powerful motivator for our 2024 goals, embodying our mission: More life for people with cancer. Read our annual report: bit.ly/49JcKCR

This week, we visited American Cancer Society's Boston Hope Lodge to serve lunch to #cancer patients and caregivers. Many patients travel long distances for quality care, but Hope Lodge provides a home-like environment close to cancer centers where patients can reside during treatment.

Our Management and Supervisory Boards issued a joint reasoned statement unanimously recommending shareholders accept the proposed acquisition offer by Novartis and tender their shares. For more information and key shareholder details, read on: bit.ly/3PZPatP

At the upcoming #ASCO24 annual meeting, we’re presenting new efficacy and safety data from our Phase 3 MANIFEST-2 trial evaluating our investigational BET inhibitor in combination with a JAK inhibitor in #myelofibrosis. Learn more: bit.ly/3U9VujH

Our Q1 2024 financial results are now available. The proposed acquisition by Novartis is advancing steadily, and we anticipate its closure in the first half of this year. For more information and key shareholder details, read on: bit.ly/44mUZqV

On #NationalCancerSurvivorsDay, we’re reminded of the crucial need to advocate for #myelofibrosis patients through diagnosis, treatment and beyond. We’re committed to learning from people impacted by the disease, like Vincenza, so that we can better support them. #NCSD2024

On #Juneteenth, we celebrate the strength, culture and achievements of the Black community and honor this pivotal chapter of American history. This #FreedomDay, we’re taking time to reflect on the significance of this day and importance of a more inclusive future.

Patient advocacy groups help people living with #MPNs navigate their diagnosis. This #MPNAwarenessDay, see how these organizations are helping these individuals find and elevate their voice. · The Leukemia & Lymphoma Society · @MPNAdvocacy · MPN Research Foundation · MPN Voice · Global MPN Scientific Foundation · Cancer Research & Treatment Fund · MPNAdvocatesNetwork #BCAM24